Receive free Biotech updates
We’ll send you a myFT Daily Digest email rounding up the latest Biotech news every morning.
A biotech company backed by Chinese conglomerate Fosun Group and private equity giant Warburg Pincus has begun one of the first mid-stage human trials of a drug discovered and designed by artificial intelligence.
Insilico Medicine, which was founded by Latvian-born scientist Alex Zhavoronkov, said it had dosed a patient in China with a novel therapy to treat the…
Read the full article here
